Merck’s Gefapixant: FDA Questions Whether Small Reduction In Chronic Cough Is Clinically Meaningful

 
• By Brenda Sandburg
  
Cough
FDA panel to consider clinical data on Merck's drug for treatment of chronic cough • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers